Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. NOW
3. TSLA
4. TXN
5. GOOG
6. IBM
7. LVS
8. INTC
9. RJF
10. KNX

Go back to Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
(NASDAQ: KYMR) Delayed: 110.34 --0 (-0%)
Previous Close $110.34    52 Week High $ 
Open $110.34    52 Week Low $ 
Day High $110.34    P/E N/A 
Day Low $110.34    EPS $ 
Volume 2,776